Heron Therapeutics’ Cooperation Agreement with Rubric Capital and Velan Capital

Kirkland & Ellis advised Heron Therapeutics on the deal.Heron Therapeutics, Inc. (NASDAQ: HRTX) announced that it has entered into a cooperation agreement with two of its shareholders,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now